Diagnostic Value of Exhaled Carbon Monoxide as an Early Marker of Exacerbation in Children with Chronic Lung DiseasesReportar como inadecuado

Diagnostic Value of Exhaled Carbon Monoxide as an Early Marker of Exacerbation in Children with Chronic Lung Diseases - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

ISRN PediatricsVolume 2012 2012, Article ID 859873, 4 pages

Clinical Study Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo 11321, Egypt

Received 14 July 2012; Accepted 9 August 2012

Academic Editors: T. V. Brogan and J. A. O-Neill

Copyright © 2012 Karima A. Abd EL Khalek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Chronic airways infection and inflammation are leading causes of morbidity and mortality in chronic lung diseases CLD. Pulmonary exacerbations are major causes of morbidity in CLD. Exhaled carbon monoxide eCO is a product of endogenous metabolic processes whose presence in exhaled breath is considered an index of inflammatory processes. Objective. To evaluate carbon monoxide eCO as inflammatory marker for early detection of acute exacerbation in CLD. Methods. Case control study included 40 children with CLD twenty in exacerbation, group I and twentyin quiescent period, group II recruited from the Chest Clinic, Children’s Hospital, Ain Shams University. Twenty apparently healthy children were included as controls group III. Results. Patients’ mean age was 9.98 ± 3.29 years: 24 60% males and 16 40% females. The mean eCO level among patients during exacerbation was 5.35 ± 1.35 ppm compared to 2.65 ± 0.49 ppm in quiescent stage and 1.30 ± 0.47 ppm in controls. eCO cutoff value discriminating cases and control was 1.5 ppm sensitivity; 100% and specificity 70% and cutoff value discriminating group I from group II was 3 ppm sensitivity: 100% and specificity: 100%. Conclusion. Exhaled CO can be considered a noninvasive early marker of acute exacerbation of CLD.

Autor: Karima A. Abd EL Khalek, Magda Y. EL Seify, Omneya I. Youssef, and Mona M. Badr

Fuente: https://www.hindawi.com/


Documentos relacionados